glutathione and triple negative breast cancer Dual metabolic targeting liposomes potentiate triple-negative radiosensitivity via glucose starvation Ratiometrically designed nanoprodrug for triple-negative
Ratiometrically designed nanoprodrug for triple negative breast cancer treatment Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect GPX4 Inhibitor Resistance and Metastatic Features in TripleNegative Breast Cancer Sabatier 2026 Advanced Science Wiley Online Library Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



